Results: 40

Comorbilidades y factores asociados en pacientes con alopecia areata
Comorbidities and associated factors in patients with alopecia areata i: en

Medisan; 26 (6), 2022
Introducción: La alopecia areata en una enfermedad autoinmune caracterizada por la pérdida no cicatricial de pelo; puede ser catalogada como un problema estético, sin tener en cuenta que tiene alto impacto en la calidad de vida de quien la padece. Objetivo: Identificar las comorbilidades, el impacto p...

Efluvio telógeno y Covid-19
Telogen effluvium and Covid-19

The first case of infection by the virus SARS-CoV-2 was reported in China in the late 2019. The disease caused by this virus was called COVID-19 and was declared as a global pandemic by World Health Organization in March 2020. Among the consequences caused by the virus, some dermatological pathologies ha...

Characteristics of telogen effluvium in COVID-19 in western Iran (2020)

An. bras. dermatol; 96 (6), 2021
Abstract Background: Although COVID-19 pandemic significantly induces mortality, many of the patients who recovered present other medical problems such as alopecias. Telogen effluvium is a common alopecia that is usually related to previous events such as acute febrile diseases, including COVID-19. Obj...

Moniletrix of the scalp from almost normal aspect to total alopecia: variable intrafamilial expressiveness

An. bras. dermatol; 96 (5), 2021
Abstract Monilethrix is a rare defect of the hair shaft, with most cases showing an autosomal dominant pattern of inheritance and variable clinical expression. It is characterized by hypotrichosis secondary to hair fragility. The diagnosis is made through trichoscopy, detecting typical findings such as p...

Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata

An. bras. dermatol; 96 (5), 2021
Abstract Background: Alopecia areata (AA) is a hair disease that causes hair loss without scarring. The etiopathogenesis of AA has not been fully understood yet. Objective: To determine serum interleukin levels (IL-2, IL-4, IL-15, and IL-17) in patients diagnosed with alopecia areata and to investigate...

Acute telogen effluvium triad after resolution

An. bras. dermatol; 96 (5), 2021
Abstract Five cases of telogen effluvium undergoing resolution are shown, with the presence of frontal, bitemporal, and occipital hair regrowth. Diagnosing acute telogen effluvium after the end of the active phase can be challenging, especially when the pull test is negative. The differential diagnosis i...

Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology

An. bras. dermatol; 95 (supl.1), 2020
Abstract Background: Alopecia areata is a highly frequent disease with an impact on quality of life and several treatment options with little clinical confirmatory evidence. Objective: To disseminate the recommendations of Brazilian dermatologists with expertise in the treatment of alopecia areata. Me...